Disease/Infection News

RSS

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

In a Nature News opinion piece, James Shelton, science adviser for USAID's Bureau for Global Health, discusses media coverage of recent findings from the journal Lancet Infectious Diseases showing that women's use of hormonal contraception (HC) may increase the risk of HIV acquisition or transmission.

4 Nov 2011

PlusNews reports on importance of cost-effectiveness of ZAMSTAR study for policymakers, donors amid economic downturn

PlusNews reports on the results of the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) study released on Monday at the International Lung Health Conference in Lille, France, which show that "home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent."

4 Nov 2011

Measles virus develops a strategy of diabolic elegance

Mayo Clinic researchers have discovered why measles, perhaps the most contagious viral disease in the world, spreads so quickly. The virus emerges in the trachea of its host, provoking a cough that fills the air with particles ready to infect the next host. The findings may also help in the fight against ovarian, breast and lung cancers.

3 Nov 2011

Study outlines evolution of malaria, leishmaniasis and trypanosomiasis

One of the most comprehensive analyses yet done of the ancient history of insect-borne disease concludes for the first time that malaria is not only native to the New World, but it has been present long before humans existed and has evolved through birds and monkeys.

3 Nov 2011

EBV vaccine could prevent mononucleosis and cancers linked to virus

In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.

3 Nov 2011

Synthetic artemisinin discovery could make malaria treatments more affordable, accessible

"Scientists at the University of California, Berkeley, and the biotech start-up Amyris have developed a process to manufacture artemisinin, a crucial ingredient in first-line malaria drugs that until now had to be extracted from a natural crop called sweet wormwood," PBS NewsHour reports.

3 Nov 2011

UC Merced professor designs powerful chemical inhibitor against HIV

In a significant step toward reducing the threat of HIV, UC Merced Professor Patricia LiWang has designed what may be the most effective chemical inhibitor against infection of the virus.

3 Nov 2011

Nearly half of pregnant women in Southern China's poor areas do not get tested for syphilis, study shows

"Nearly half of pregnant women do not get tested for syphilis in poor areas of southern China where the sexually transmitted disease has seen a resurgence, researchers said Wednesday" in a study published in the WHO's November 2011 Bulletin, the Associated Press/Washington Post reports.

3 Nov 2011

New version of chitosan effective in capturing flu virus

With flu season just around the corner, scientists are reporting development of a new material for the fiber in face masks, air conditioning filters and air cleaning filters that captures influenza viruses before they can get into people's eyes, noses and mouths and cause infection. The report on the fiber appears in ACS' journal Biomacromolecules.

3 Nov 2011

IP-K and Sanofi form new HBV research collaboration

One of the most common and serious infectious diseases, Hepatitis B, is to be targeted in a new collaborative venture between the internationally-renowned translational research institute, Institut Pasteur Korea (IP-K), and the Korean arm of the leading global healthcare company, Sanofi-Aventis Korea. The goal is to develop and validate a high throughput assay to screen IP-K's chemical libraries for novel compounds that can be developed as new drugs.

3 Nov 2011

Final results from Medivir's TMC435 phase IIb study on genotype-1 hepatitis C

Medivir AB, a research-based speciality pharmaceutical company focused on infectious diseases, today announces final results from the ASPIRE study.

3 Nov 2011

New, poison-free approach to malaria control

With a new, poison-free approach to malaria control, researchers in the Solarmal project have expressed not only the hope to eliminate malaria in Africa at local level, but also to provide the local population with a source of sustainable energy. Research into this combined approach was facilitated due to a donation to Wageningen University Fund by the COmON foundation.

2 Nov 2011

Advocates push for integration of HIV/TB funding, programming in Kenya

This post in the Center for Global Health Policy's "Science Speaks" blog reports on a presentation at the Union World Conference on Lung Health in France on Saturday by Evelyne Kibuchi, a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), writing, "HIV stakeholders have been slow to embrace and adopt TB interventions, Kibuchi said, and resources for co-infection activities are modest.

2 Nov 2011

Zanzibar's Islamic leaders use Qur'an to shift attitudes about sex, contraception, HIV/AIDS

The Guardian's "Poverty Matters Blog" examines how religious leaders on the island of Zanzibar, a semi-autonomous part of Tanzania, are using the Qur'an to shift attitudes about the issues of sex, contraception, and HIV/AIDS in an effort to reduce HIV infection, improve maternal health and curb rapid population growth. "Their aim is to shift deep-rooted views in their devout Islamic society that contraception is a sin," according to the blog.

2 Nov 2011

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Multidrug-resistant Acinetobacter baumannii (MDR-AB) was found in the environment of 48 percent of the rooms of patients colonized or infected with the pathogen, according to a new study published in the November issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

2 Nov 2011

Elevated body temperature helps certain types of immune cells to work better

With cold and flu season almost here, the next time you're sick, think twice before taking something for your fever. That's because scientists have found more evidence that elevated body temperature helps certain types of immune cells to work better.

2 Nov 2011

Science Speaks reports results of Zambia-South Africa TB and AIDS Reduction program study

This post in the Center for Global Health Policy's "Science Speaks" blog reports the results of a Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) program study, released Monday, which "demonstrate that household counseling -- defined as the unpacking of concerns about TB and HIV within households and facilitating prompt diagnosis and treatment -- significantly reduced tuberculosis (TB) prevalence."

2 Nov 2011

Exclusion of family planning, HIV prevention from Pink Ribbon Red Ribbon partnership is 'counter-intuitive'

In this Huffington Post opinion piece, Serra Sippel, president of the Center for Health and Gender Equity, examines the Pink Ribbon Red Ribbon partnership, which was launched last month by PEPFAR in conjunction with the George W. Bush Institute, Susan G. Komen for the Cure, and UNAIDS with the aim of "integrating cervical and breast cancer education, screening, and treatment with HIV services."

2 Nov 2011

Innovative mobile-technology strategy to prevent HIV/AIDS in Uganda

1 million people in Uganda live with HIV/AIDS, where long distances and expensive travel costs significantly limit access to treatment. By employing an innovative mobile-technology strategy, Dr. Femida Gwadry-Sridhar, Director of I-THINK Research at Lawson Health Research Institute, hopes to provide a much-needed solution.

2 Nov 2011

First study to show how H. pylori toxin can spur apoptosis

Researchers report they have figured out how the cancer-causing bacterium Helicobacter pylori attacks a cell's energy infrastructure, sparking a series of events in the cell that ultimately lead it to self-destruct.

2 Nov 2011

Disease/Infection News

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

PlusNews reports on importance of cost-effectiveness of ZAMSTAR study for policymakers, donors amid economic downturn

Measles virus develops a strategy of diabolic elegance

Study outlines evolution of malaria, leishmaniasis and trypanosomiasis

EBV vaccine could prevent mononucleosis and cancers linked to virus

Synthetic artemisinin discovery could make malaria treatments more affordable, accessible

UC Merced professor designs powerful chemical inhibitor against HIV

Nearly half of pregnant women in Southern China's poor areas do not get tested for syphilis, study shows

New version of chitosan effective in capturing flu virus

IP-K and Sanofi form new HBV research collaboration

Final results from Medivir's TMC435 phase IIb study on genotype-1 hepatitis C

New, poison-free approach to malaria control

Advocates push for integration of HIV/TB funding, programming in Kenya

Zanzibar's Islamic leaders use Qur'an to shift attitudes about sex, contraception, HIV/AIDS

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Elevated body temperature helps certain types of immune cells to work better

Science Speaks reports results of Zambia-South Africa TB and AIDS Reduction program study

Exclusion of family planning, HIV prevention from Pink Ribbon Red Ribbon partnership is 'counter-intuitive'

Innovative mobile-technology strategy to prevent HIV/AIDS in Uganda

First study to show how H. pylori toxin can spur apoptosis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News